Skip to Main Content

Author Details

Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
2002
134
54
PMIDPaper TitleJournal TitlePublished Year
38047392NIPBL::NACC1 Fusion Hepatic Carcinoma.Am J Surg Pathol2024
37652664The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.Cold Spring Harb Mol Case Stud2024
38047392NIPBL::NACC1 Fusion Hepatic Carcinoma.Am J Surg Pathol2024
37652664The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.Cold Spring Harb Mol Case Stud2024
35968961GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.Am J Surg Pathol2023
35968961GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.Am J Surg Pathol2023
37587346Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.Nature2023
37919447Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37704749Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37489101Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.Am J Surg Pathol2023
37223924Immunogenomic Landscape of Neuroendocrine Prostate Cancer.Clin Cancer Res2023
37919447Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37489101Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.Am J Surg Pathol2023
37704749Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37587346Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.Nature2023
37223924Immunogenomic Landscape of Neuroendocrine Prostate Cancer.Clin Cancer Res2023
34676924Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.Adv Mater2022
35510953Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med2022
35644123Weakly-supervised tumor purity prediction from frozen H&E stained slides.EBioMedicine2022
35637420Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.Nat Biotechnol2022
35490048A multidisciplinary approach to optimize primary prostate cancer biobanking.Urol Oncol2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35483877Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.Cold Spring Harb Mol Case Stud2022
36414761Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging.Nat Methods2022
36387205Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment.Front Oncol2022
36316562Unsupervised discovery of tissue architecture in multiplexed imaging.Nat Methods2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
35046520Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.Br J Cancer2022
34676924Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.Adv Mater2022
35231161The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.Mol Oncol2022
35230579RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.Ann Surg Oncol2022
34773394Fine-needle aspiration biopsy of growing teratoma syndrome as a diagnostic pitfall of metastatic adenocarcinoma.Diagn Cytopathol2022
34483300Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Int J Gynecol Pathol2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
35050902Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.JCI Insight2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35510953Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med2022
35644123Weakly-supervised tumor purity prediction from frozen H&E stained slides.EBioMedicine2022
35637420Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.Nat Biotechnol2022
35490048A multidisciplinary approach to optimize primary prostate cancer biobanking.Urol Oncol2022
35483877Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.Cold Spring Harb Mol Case Stud2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
36414761Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging.Nat Methods2022
36387205Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment.Front Oncol2022
36316562Unsupervised discovery of tissue architecture in multiplexed imaging.Nat Methods2022
35046520Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.Br J Cancer2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
35050902Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.JCI Insight2022
35231161The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.Mol Oncol2022
35230579RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.Ann Surg Oncol2022
  • 1 - 50 of 268

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 13
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 37
University of British Columbia
Career Start Year 2014
Number of shared co-authors 2
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 5
University of British Columbia
Career Start Year 2011
Number of shared co-authors 25
University of Bern
Career Start Year 2009
Number of shared co-authors 24
University of Basel
Career Start Year 2008
Number of shared co-authors 27
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 21
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 13
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 58
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 44
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 10
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 13
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 4
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 3
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 34
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 2
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 3
Monash University
Career Start Year 2000
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 13
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 19
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 9
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 16
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 7
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 14
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 57

Collaborators

University of Bern
Co-authored papers 74
Institute for Computational Biomedicine
Co-authored papers 53
Meyer Cancer Center
Co-authored papers 50
Dana-Farber Cancer Institute
Co-authored papers 49
Sandra and Edward Meyer Cancer Center
Co-authored papers 32
University of Trento
Co-authored papers 30
Sandra and Edward Meyer Cancer Center
Co-authored papers 23
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 23
New York University Langone Health
Co-authored papers 22
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 22
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 19
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 18
Case Western Reserve University
Co-authored papers 18
Weill Cornell Medical College
Co-authored papers 17
Sandra and Edward Meyer Cancer Center
Co-authored papers 14
University of Trento
Co-authored papers 12
University of Michigan Medical School.
Co-authored papers 12
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 12
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 12
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 11
Sandra and Edward Meyer Cancer Center
Co-authored papers 10
Englander Institute for Precision Medicine
Co-authored papers 10
Institut Curie, CNRS, PSL Research University
Co-authored papers 10
University Hospital Zurich
Co-authored papers 10
Broad Institute of Harvard and MIT
Co-authored papers 9
University of Trento
Co-authored papers 9
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 9
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers 9
New York-Presbyterian Hospital-Weill Cornell Medical College
Co-authored papers 9
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 9